Carmen Escuriola-Ettingshausen

4PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 06, 2026
Update: Immune Tolerance Induction Practice in Haemophilia.

|May 11, 2026
Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting.

|Feb 10, 2025
Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update.

Carmen Escuriola Ettingshausen, Riitta Lassila, Gines Escolar

|Dec 02, 2024
Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary.

Carmen Escuriola Ettingshausen, Wolfgang Eberl, Hermann Eichler

Pageof 1

Frequent Collaborators

1 joint publications

Katharina Holstein

1 joint publications

Riitta Lassila

1 joint publications

Gines Escolar

1 joint publications

Christoph Male